PREVALENCE OF HEPATITIS C VIRUS INFECTION IN NON INSULIN DEPENDENT DIABETIC PATIENTS (NIDDM)

Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2015, Vol 2, Issue 34

Abstract

The present study was done to evaluate the prevalence of hepatitis C virus (HCV) infection in non-insulin dependent diabetic patients (NIDDM) and to investigate influence of HCV seropositivity on several factors such as age of onset of diabetes, complications and mode of treatment. METHODS: The study is prospective, hospital based case - control study done over a period of 3 years. A total of 428 diabetic patients were compared with 1800 voluntary blood donors for the presence of HCV infection. Serological testing for anti HCV was done by using commercial enzyme linked immunosorbent assay (ELISA). Data about various variables were collected from diabetic patients using a structured questionnaire after taking informed consent. RESULTS: Higher prevalence of HCV (7.71%) infection rate observed in NIDDM patients in comparison with blood donors (1.1%). In our study, HCV seropositivity is highest (11.81%) in 40- 50 years age group followed by (8.57%) 30-40 years age and least (2.43%) in age > 61 years. Mean age of onset of diabetes mellitus (DM) is 39 years in HCV +ve patients in comparison with 46 years in non-reactors. Proportion of seropositive cases among male and female diabetic cases did not show significant difference. Out of 33 HCV seropositive cases, 63.64% managed with insulin and 48.49% oral hypoglycemic drugs with insulin supplement. Ten out of 33 (30.30%) HCV seropositive cases presented with one or more late diabetic complications compared to 78 out of 395 (19.75%) seronegative cases, with diabetic nephropathy being commonest one. CONCLUSION: Although, HCV infection is more common among adults with type 2 diabetes, it is uncertain whether HCV infection precedes the development of diabetes. Hence, there is a need to perform a prospective analysis to investigate, in persons who acquire type 2 diabetes whether they are more likely to have had antecedent HCV infection.

Authors and Affiliations

Sreedhara H. G. , Rudramuneswara Swamy B. P. , Mahantesh S. , Vijayakumara H. G. , Nagaraj E. R.

Keywords

Related Articles

CARDIAC MYXOMA- A STUDY OF 10 CASES

BACKGROUND Myxoma is the most common primary tumour of the heart in adults with age range of 30 to 60 years. About 90% of them are situated in left atrium. Here we present a study of 10 cases of cardiac myxomas. MATERIAL...

RUPTURE OF A PREVIOUSLY SCARRED UTERUS AT 26 WEEKS OF GESTATION

Rupture of the gravid uterus is a catastrophic event to both mother and fetus. Majority of cases occur in women with scarred uteri. This is the case report of a 28 year old lady, G2 P 1 L 1 with 26 weeks of gestation wit...

ATOLL SIGN IN CRYPTOGENIC ORGANIZING PNEUMONIA

BACKGROUND Cryptogenic Organizing Pneumonia (COP) is one of the major idiopathic interstitial pneumonia (IIP) according to revised American Thoracic Society/ European Respiratory Society (ATS/ERS) classification of IIP....

CYTOMORPHOLOGICAL PATTERN OF LYMPH NODE LESIONS- A FIVE YEAR STUDY IN REGIONAL INSTITUTE OF MEDICAL SCIENCES, IMPHAL

BACKGROUND Lymph nodes are an important part of immune system. Their enlargement is noted in a wide spectrum of diseases, including infections and malignancies, which are a common finding in clinical practice. Lymphadeno...

MOLECULAR ANALYSIS OF LGI4 GENE MUTATION IN JUVENILE MYOCLONIC EPILEPSY PATIENTS IN DRAVIDIAN LINGUISTIC POPULATION IN SOUTH INDIA

Juvenile Myoclonic Epilepsy (JME) or Janz syndrome is inherited disorder, otherwise neurologically normal. (1) The prevalence of JME is estimated around 3 in 10, 000. The genetic mutations in JME patients affecting non-i...

Download PDF file
  • EP ID EP231698
  • DOI 10.18410/jebmh/2015/733
  • Views 103
  • Downloads 0

How To Cite

Sreedhara H. G. , Rudramuneswara Swamy B. P. , Mahantesh S. , Vijayakumara H. G. , Nagaraj E. R. (2015). PREVALENCE OF HEPATITIS C VIRUS INFECTION IN NON INSULIN DEPENDENT DIABETIC PATIENTS (NIDDM). Journal of Evidence Based Medicine and Healthcare, 2(34), 5269-5278. https://europub.co.uk/articles/-A-231698